As we head into a long Thanksgiving weekend (in the US at least), I thought I’d write a quick thank you to everyone who has supported this blog in 2009. It has far exceeded my expectations and I continue to be amazed and flattered by the comments I receive via email, Twitter, and, more recently, in person. I launched this blog very late in 2008 with a few test posts, but really started dedicating time to at the beginning of this year. As a special thanks, read through to the end to get a special offer for all my dedicated readers (and if you’re reading this during Thanksgiving break, you’re dedicated).
In 2009, almost 50,000 unique visitors have stopped by and almost 1,200 of you are subscribers. I was doing a little analysis and found it interesting to see what the most read posts were for 2009 to date and thought I’d share this with you.
- By far, the number one post isn’t a post at all, but the Pharma and Healthcare Social Media Wiki. Not surprising for those of you who are regular visitors. I’ve seen the wiki referenced hundreds of places since it launched in February with about 20 examples of pharma social media. Now it has more than 450 (including industry observers, like me). I owe many of the submissions to all of you, so thanks for your contributions. The wiki has been viewed well over 30,000 times since it’s launch.
- One of the most tweeted posts of the year was Ten Digital Marketing Ideas Pharma Companies Will Never Try (But Should). It is also the most read post of the year and remains one of my personal favorites.
- The most commented on post of the year so far is Pharma Should Forget About Social Media Monitoring. It’s also the second most read post. This one generated quite a bit of debate on both sides, which, frankly, is what I was hoping would happen. It’s an important topic that needs to be discussed even further.
- One of my favorite titled posts, FDA Uses Social Media, But You Can’t, is the third most read post so far in 2009. This was published long before any of us thought the FDA would actually have a hearing on social media and this post surprised quite a few people who were amazed to see how much the FDA and CDC were doing with social media themselves while we all sat on the sidelines.
- One of the posts that got the most interest from non-pharma people was my post on How to Avoid FDA Regulations Using Mobile Marketing. Quite a few blogs in the mobile marketing arena picked up on this and sent a lot of visitors making it the number four post of the year so far.
- The number five post of the year so far is one of my personal favorites as well: The Myth of Adverse Event Reporting. I wrote this way back in January before there was much debate on AEs and how to handle them. This was one of the first posts to refer to the Nielsen data on the incidence of adverse events in healthcare social media discussions that everyone is now so familiar with.
- The most downloaded white paper of the year so far is The Future of Healthcare Relationship Marketing with 2325 downloads (and counting) so far this year.
And speaking of white papers, I’ll be releasing one next week that will include two posts that will also come out next week (UPDATE: this is now available): “The Biggest Mistakes in Relationship Marketing” and “The 7 Golden Rules in Relationship Marketing.” Both will come with a POWERPoint version (including notes). The former is coming out on Tuesday (Dec. 1) and the latter on Thursday (Dec. 3) of next week. However, as a special thanks to those of you who are reading this and have supported me all along, I’d like to send you a copy of a white paper that combines both posts before anyone else gets it. I’ll send this out to you on Wednesday (Dec. 2), which means you’ll be the first to see “The 7 Golden Rules of Relationship Marketing” before it goes public. The combined white paper won’t be available for the public until at least December 9. It’s not a new car or anything, but it’s something…
If you’re interested, just fill out the form below (note: your email address will only be used to send this one white paper and not for any other purpose). This form generally does not work if you’re reading this on an email platform or some RSS readers. If you’re having trouble, click through to the post to use the form.
Thanks again for your support so far and I hope I can continue to provide more valuable content to keep you coming back in the future.